Medical Device Network on MSN
Coronary plaque reimbursement presages CAD care evolution
Plaque analysis is now formally recognised, widely accepted, and reimbursable by insurers in the US, including Medicare.
Background: Middle-aged and older endurance athletes have increased prevalence of coronary artery disease (CAD) on coronary CT angiography (CCTA) compared to healthy controls, despite similarly low ...
AccuLine has published new results from a clinical trial of the CORA system for coronary artery disease (CAD) evaluation, ...
The bank said HeartFlow stands to benefit from a structural shift toward coronary CT angiography, or CCTA, which it described ...
Cardiac magnetic resonance imaging (MRI) is an appropriate non-invasive procedure for functional diagnostics in patients who, ...
Fast-RSOM skin scan identifies early cardiovascular risk by imaging tiny blood vessels and functional changes before symptoms ...
With no difference in death or MI, Kevin Bainey says doctors can give medical therapy a good try before sending patients for ...
Older athletes are not ‘bulletproof,’ so a clinical review recommends guidelines for cardiovascular imaging, but the ...
Background Cardiogenic shock (CS) complicating acute myocardial infarction (AMI) carries high mortality. Early ...
The dual approach, though rare, was linked to fewer 2-year MACE and lower long-term costs compared with angiography alone.
Coverage unlocks reimbursable AI plaque quantification, advancing coronary risk assessment in everyday cardiology practice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results